Navigation Links
Zimmer Acquires NORMED Medizin-Technik GmbH
Date:6/4/2013

WARSAW, Ind., June 4, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired Tuttlingen, Germany-based NORMED Medizin-Technik GmbH, a provider of innovative technologies for the foot and ankle, hand and wrist reconstruction and trauma markets. 

NORMED develops a broad range of specialized plates, screws and instruments, including systems for bone reconstruction and fracture repair, fusion procedures and external fixation.  The acquisition of NORMED will strengthen Zimmer's Extremities and Trauma product portfolios and new product development capabilities in the fast growing foot and ankle and hand and wrist segments.

About Zimmer Holdings, Inc.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2012 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 8,500 employees worldwide.

About NORMED Medizin-Technik GmbH
Founded in 1988 and located in Tuttlingen, Germany, Normed Medizin-Technik GmbH is an innovative global medical company that provides a broad range of plates, screws and specialized instruments for foot and ankle and hand and wrist surgeries.

Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zimmer Holdings to Present at Deutsche Bank Securities Annual Health Care Conference
2. Zimmer Acquires Knee Creations, LLCs Business
3. Zimmer Holdings, Inc. Reports First Quarter 2013 Financial Results
4. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
5. Zimmer Launches Single Injection Pain Relief Solution at the 2013 AAOS Annual Meeting
6. UPDATE: Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
7. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
8. Zimmer Holdings to Present at Canaccord Genuitys Musculoskeletal Conference
9. Zimmer Holdings to Present at Barclays Capital 2013 Global Healthcare Conference
10. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
11. Zimmer Reports Fourth Quarter and 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017  Kratom leaves, from a ... are often used to prepare tea-like beverages and ... million Americans annually to increase alertness, enhance well-being ... for minor aches and pains. PinneyAssociates, review of ... to assist FDA and DEA in determining the ...
(Date:1/18/2017)... , Jan. 18, 2017 Safe Rx ... of pharmacies based in Loveland, Colorado ... Vials (LPVs) in selected Good Day locations.     ... a cost-effective alternative for secure storage," said Milton ... less than the price of a cup of coffee, ...
(Date:1/18/2017)... 2017 Invetech, the leading developer of ... therapies , has announced a collaboration agreement with ... starvation" treatments for acute leukemia and other oncology ... Invetech will develop systems to enable the commercial-scale ... technology platform, which uses a novel technology to ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers ... and wrinkles. Few people know that popular cosmetic fillers can enhance ... who is medical director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, ...
(Date:1/18/2017)... FL (PRWEB) , ... January 18, 2017 , ... ... to manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , ... often go untreated. , Certain Dri created this infographic to explain the seven ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
(Date:1/18/2017)... ... January 18, 2017 , ... Park ... financial planning services to families and business owners in the greater Kansas City ... children with developmental disabilities. , The Lakemary Center is a comprehensive educational resource ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. ... website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President ... the field of biosimilars through thought leader interaction in, live video and interactive ...
Breaking Medicine News(10 mins):